文献速递胸部CT

肺癌患者筛查合格率与低剂量CT利用的回顾性队列研究

Analysis of Lung Cancer Screening Eligibility Among Patients Diagnosed With Lung Cancer: A Retrospective Cohort Study.
PubMed 文献 · J Am Coll Radiol · 2026-07-17

本研究回顾性纳入2018-2024年美国南加州一家三级医疗系统诊断为原发性肺癌的1867例50-80岁患者,评估USPSTF 2021标准下的肺癌筛查合格率。结果显示13.2%(148/1119)符合筛查标准,符合者中仅9.5%(13/137)在诊断前2年内完成低剂量CT。研究强调现有筛查标准覆盖有限且低剂量CT利用率不足。

要点

  • 肺癌患者中仅13.2%符合USPSTF 2021筛查标准
  • LCS合格者中仅9.5%诊断前完成低剂量CT
  • 女性、亚裔及西班牙裔更不易符合筛查标准

核心结论

  • USPSTF 2021标准仅能识别13.2%的肺癌患者,现存筛查资格标准覆盖范围有限
  • 筛查合格患者中低剂量CT完成率仅9.5%,反映筛查利用率不足
  • 女性、亚裔、其他或混合种族及西班牙裔符合筛查资格的可能性更低

研究设计与样本

  • 回顾性队列研究,纳入2018-2024年美国南加州三级医疗系统1867例50-80岁原发性肺癌患者
  • 使用电子病历结构化吸烟史判定2021 USPSTF肺癌筛查合格性
  • 次要结局包括诊断时有效USPSTF指南下筛查合格患者诊断前2年内低剂量CT完成情况
  • 同时评估电子病历结构化吸烟史完整性及社会人口学特征与各结局的关联

诊断标准与关键数值

  • 2021 USPSTF标准下肺癌筛查合格率为13.2%(148/1119)
  • 筛查合格患者中低剂量CT完成率为9.5%(13/137)

临床应用与阅片要点

  • 放射科在肺癌筛查中需注意现标准下大量肺癌患者并不符合筛查资格
  • 筛查合格患者实际低剂量CT利用率很低,报告及随访环节需关注筛查路径依从性
  • 亚裔及其他种族、女性、西班牙裔在现行标准下更可能漏于筛查外

局限性

  • 研究为单中心回顾性设计
  • 电子病历结构化吸烟史不完整,仅1119例可判定筛查合格性
  • 未报告筛查不合格肺癌患者的具体排除原因分布

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We evaluated lung cancer screening (LCS) eligibility rate under US Preventive Services Task Force (USPSTF) criteria among patients diagnosed with primary lung cancer and examined LCS utilization before lung cancer diagnosis.

METHODS: Patients aged 50 to 80 years with a lung cancer diagnosis in 2018-2024 who received care at a tertiary health system in Southern California were included. LCS eligibility was determined using available structured smoking history in the electronic medical record. The primary outcome was LCS eligibility using 2021 USPSTF guidelines. Secondary outcomes included low-dose CT (LDCT) completion among LCS-eligible patients during the 2 years preceding their diagnosis based on USPSTF guideline in effect at diagnosis time, the completeness of electronic medical record structured smoking history, and the associations between sociodemographic characteristics and these outcomes.

RESULTS: In all, 1,867 patients were included (mean age 67 ± 8 years, 51.6% [962 of 1,866] male, 53.4% [955 of 1,790] White, 2.4% [43 of 1,790] Black, 31.5% [564 of 1,790] Asian). Further, 11.6% (208 of 1,786) were Hispanic. At diagnosis, 46.3% (786 of 1,697) were never smokers, 44.5% (756 of 1,697) were former smokers, and 9.1% (155 of 1,697) were current smokers. LCS eligibility was determined for 1,119 patients, of whom 13.2% (148 of 1,119) met eligibility criteria according to the 2021 USPSTF guidelines. Multivariable analysis showed women (odds ratio [OR] 0.32; 95% confidence interval [CI], 0.21-0.47; P < .001), Asian race (OR 0.35; 95% CI, 0.20-0.62; P < .001), other or mixed race (OR 0.48; 95% CI, 0.24-0.97; P = .04), and Hispanic ethnicity (OR 0.38; 95% CI, 0.17-0.82; P = .01) were less likely to be LCS-eligible. Among the 137 eligible patients, only 13 (9.5%) had received LDCT.

CONCLUSION: Our findings emphasize two critical barriers to effective LCS: the limited reach of existing eligibility criteria and inadequate uptake of LDCT.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Sharifian, Tran, Cespedes-Gomez, et al. Analysis of Lung Cancer Screening Eligibility Among Patients Diagnosed With Lung Cancer: A Retrospective Cohort Study. J Am Coll Radiol. 2026. PMID: 42468819. doi:10.1016/j.jacr.2026.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。